A carregar...
Esketamine clinical trials: reply to Maju et al.
Maju et al. provided clarifications on important and controversial issues related to esketamine clinical trial data, in response to a vivid debate triggered by the marketing authorisation recently granted by this new medicine. In this commentary, we reply to their comments attempting to critically d...
Na minha lista:
| Publicado no: | Epidemiol Psychiatr Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cambridge University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214734/ https://ncbi.nlm.nih.gov/pubmed/32345395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S204579602000027X |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|